Skip to content

Drug interactions

Ozanimod + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Moderate

Ozanimod and Sofosbuvir-velpatasvir-voxilaprevir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Velpatasvir and voxilaprevir inhibit BCRP, and ozanimod's active metabolites are BCRP substrates. Exposure to these metabolites may rise and increase ozanimod adverse effects.

What this interaction means in plain words

Ozanimod and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ozanimod belongs to Central Nervous System; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Low

Why it happens

BCRP inhibition by velpatasvir and voxilaprevir may raise ozanimod metabolite exposure.

What to do

Consider an alternative immunomodulator during HCV treatment. If used together, monitor heart rate, blood pressure and liver enzymes.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ozanimod and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ozanimod with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as moderate. Ozanimod and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Velpatasvir and voxilaprevir inhibit BCRP, and ozanimod's active metabolites are BCRP substrates. Exposure to these metabolites may rise and increase ozanimod adverse effects.

How serious is the interaction between Ozanimod and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider an alternative immunomodulator during HCV treatment. If used together, monitor heart rate, blood pressure and liver enzymes.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in